Skip to main content
. 2022 Aug 12;12:985484. doi: 10.3389/fonc.2022.985484

Figure 3.

Figure 3

Establishment and evaluation of the 9-gene signature. (A) Kaplan-Meier survival analysis of liver cancer patients in the high-risk and low-risk groups. (B) Time dependent ROC curves of overall survival at 1, 2- and 3- years. (C) ROC curves of risk score for clinical features in liver cancer patients. (D) The C-index curve analyzes the consistency index of risk score. (E–G) The distribution of risk score, survival status, and 9-gene expression profiles for each liver cancer patient.